Sponsored By

Innophos To Acquire Novel Ingredients To Create Nearly Half Billion Nutrition Platform

Innophos Holdings, Inc. announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions primarily owned by GenNx360 Capital Partners, a New York-based private equity firm.

August 1, 2017

1 Min Read
Innophos To Acquire Novel Ingredients To Create Nearly Half Billion Nutrition Platform

Innophos Holdings, Inc. announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions primarily owned by GenNx360 Capital Partners, a New York-based private equity firm.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like